Alzheimer’s Study Testing Experimental Drug To Slow Memory Loss

Alzheimer’s Study Testing Experimental Drug To Slow Memory Loss
shutterstock_130608161A new study is now enrolling and accepting volunteers to investigate the potential of a new drug to slow the devastating effects of Alzheimer's disease on patients' memory and physical activity. Eligible participants include men and women with ages between 55 to 85 years old suffering from mild to severe Alzheimer's. Participants' partners, such as a spouse or adult children or even close friends, will also participate in the study. All the expenses related to the study, including medication, study-related procedures and testing and study care visits will be provided at no cost to the participants. Additionally, all enrolled participants will be paid for time and traveling. Alzheimer's represents a huge health and personal cost, currently affecting 5.1 million Americans. With increasing aging population, Alzheimer's incidence is expected to rise substantially, as estimated by the National Institute on Aging who reported that the risk for Alzheimer's double with every five years after the 65 years old. The study is conducted by researchers at the University of Cincinnati (UC) and led by Muhammad Aslam, MD, an associate professor in the UC Department of Psychiatry and Behavioral Neuroscience and Robert Krikorian, PhD, specialist in cognitive diseases and member of the Memory Disorders Center at the UC Neuroscience Institute. The study is sponsored by Merck Sharp & Dohme Corp, a subsidiary of Merck &
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *